Resident and Monocyte-Derived Macrophages in Cardiovascular Disease

Circulation Research

Volumn 122, Issue 1, 2018, Pages 113-127

  Honold, Lisa ^a   Nahrendorf, Matthias ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cardiovascular disease; hematopoietic system; inflammation; macrophage ontogeny; tissue resident macrophages

Indexed keywords

ADIPOSE TISSUE; ATHEROSCLEROSIS; BONE MARROW; BRAIN; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL LINEAGE; CORONARY ARTERY; DISEASE ASSOCIATION; DISEASE COURSE; HEART; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; LYMPHOCYTE DEPLETION; MACROPHAGE; MONOCYTE; NONHUMAN; ONTOGENY; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SPLEEN; TISSUE REGENERATION; ANIMAL; CELL DIFFERENTIATION; EMBRYO DEVELOPMENT; EMBRYOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; EMBRYONIC DEVELOPMENT; HUMANS; MACROPHAGES; MONOCYTES;

EID: 85040167074     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.311071     Document Type: Review

References (200)

1. van Furth R, Cohn ZA, Hirsch JG, Humphrey JH, Spector WG, Langevoort HL. The mononuclear phagocyte system: a new classification of macro-phages, monocytes, and their precursor cells. Bull World Health Organ. 1972;46:845-852.
2. Yona S, Kim KW, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A, Hume DA, Perlman H, Malissen B, Zelzer E, Jung S. Fate mapping reveals origins and dynamics of mono-cytes and tissue macrophages under homeostasis. Immunity. 2013;38:79-91. doi: 10.1016/j.immuni.2012.12.001.
3. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M. Fate mapping analysis reveals that adult microglia derive from primitive macro-phages. Science. 2010;330:841-845. doi: 10.1126/science.1194637.
4. Sheng J, Ruedl C, Karjalainen K. Most tissue-resident macrophages except microglia are derived from fetal hematopoietic stem cells. Immunity. 2015;43:382-393. doi: 10.1016/j.immuni.2015.07.016.
5. Ginhoux F, Guilliams M. Tissue-resident macrophage ontogeny and homeo-stasis. Immunity. 2016;44:439-449. doi: 10.1016/j.immuni.2016.02.024.
6. Hoeffel G, Ginhoux F. Ontogeny of tissue-resident macrophages. Front Immunol. 2015;6:486. doi: 10.3389/fmmu.2015.00486.
7. Hanna RN, Carlin LM, Hubbeling HG, Nackiewicz D, Green AM, Punt JA, Geissmann F, Hedrick CC. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-mono-cytes. Nat Immunol. 2011;12:778-785. doi: 10.1038/ni.2063.
8. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. 2007;317:666-670. doi: 10.1126/science.1142883.
9. Carlin LM, Stamatiades EG, Auffray C, Hanna RN, Glover L, Vizcay-Barrena G, Hedrick CC, Cook HT, Diebold S, Geissmann F. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell. 2013;153:362-375. doi: 10.1016/j.cell.2013.03.010.
10. Jakubzick C, Gautier EL, Gibbings SL, et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity. 2013;39:599-610. doi: 10.1016/j. immuni.2013.08.007.
11. Becher B, Schlitzer A, Chen J, Mair F, Sumatoh HR, Teng KW, Low D, Ruedl C, Riccardi-Castagnoli P, Poidinger M, Greter M, Ginhoux F, Newell EW. High-dimensional analysis of the murine myeloid cell system. Nat Immunol. 2014;15:1181-1189. doi: 10.1038/ni.3006.
12. Thomas GD, Hamers AAJ, Nakao C, Marcovecchio P, Taylor AM, McSkimming C, Nguyen AT, McNamara CA, Hedrick CC. Human blood monocyte subsets: a new gating strategy defned using cell surface markers identifed by mass cytometry. Arterioscler Thromb Vasc Biol. 2017;37:1548-1558. doi: 10.1161/ATVBAHA.117.309145.
13. Kohyama M, Ise W, Edelson BT, Wilker PR, Hildner K, Mejia C, Frazier WA, Murphy TL, Murphy KM. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature. 2009;457:318-321. doi: 10.1038/nature07472.
14. Haldar M, Kohyama M, So AY, et al. Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages. Cell. 2014;156:1223-1234. doi: 10.1016/j.cell.2014.01.069.
15. Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, Jung S, Amit I. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell. 2014;159:1312-1326. doi: 10.1016/j.cell.2014.11.018.
16. Heidt T, Courties G, Dutta P, Sager HB, Sebas M, Iwamoto Y, Sun Y, Da Silva N, Panizzi P, van der Laan AM, van der Lahn AM, Swirski FK, Weissleder R, Nahrendorf M. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ Res. 2014;115:284-295. doi: 10.1161/CIRCRESAHA.115.303567.
17. Hashimoto D, Chow A, Noizat C, et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013;38:792-804. doi: 10.1016/j. immuni.2013.04.004.
18. Scott CL, Zheng F, De Baetselier P, Martens L, Saeys Y, De Prijck S, Lippens S, Abels C, Schoonooghe S, Raes G, Devoogdt N, Lambrecht BN, Beschin A, Guilliams M. Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun. 2016;7:10321. doi: 10.1038/ncomms10321.
19. Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118:1786-1807. doi: 10.1161/CIRCRESAHA.115.306885.
20. Jaiswal S, Natarajan P, Silver AJ, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377:111-121. doi: 10.1056/NEJMoa1701719.
21. Pang WW, Schrier SL, Weissman IL. Age-associated changes in human hematopoietic stem cells. Semin Hematol. 2017;54:39-42. doi: 10.1053/j. seminhematol.2016.10.004.
22. Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D'Antoni ML, Debuque R, Chandran A, Wang L, Arora K, Rosenthal NA, Tallquist MD. Revisiting cardiac cellular composition. Circ Res. 2016;118:400-409. doi: 10.1161/ CIRCRESAHA.115.307778.
23. Epelman S, Lavine KJ, Beaudin AE, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during infammation. Immunity. 2014;40:91-104. doi: 10.1016/j.immuni.2013.11.019.
24. Leid J, Carrelha J, Boukarabila H, Epelman S, Jacobsen SE, Lavine KJ. Primitive embryonic macrophages are required for coronary development and maturation. Circ Res. 2016;118:1498-1511. doi: 10.1161/ CIRCRESAHA.115.308270.
25. Pinto AR, Paolicelli R, Salimova E, Gospocic J, Slonimsky E, Bilbao-Cortes D, Godwin JW, Rosenthal NA. An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profle. PLoS One. 2012;7:e36814. doi: 10.1371/journal. pone.0036814.
26. Hulsmans M, Clauss S, Xiao L, et al. Macrophages facilitate electrical conduction in the heart. Cell. 2017;169:510-522.e20. doi: 10.1016/j. cell.2017.03.050.
27. Woehlck HJ, McCann FV. Action potentials in human macrophages are calcium spikes. Cell Biol Int Rep. 1986;10:517-525.
28. McCann FV, Cole JJ, Guyre PM, Russell JA. Action potentials in macrophages derived from human monocytes. Science. 1983;219:991-993.
29. Gallin EK, Livengood DR. Nonlinear current-voltage relationships in cultured macrophages. J Cell Biol. 1980;85:160-165.
30. Ensan S, Li A, Besla R, et al. Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol. 2016;17:159-168. doi: 10.1038/ ni.3343.
31. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204:3037-3047. doi: 10.1084/ jem.20070885.
32. Li W, Hsiao H-M, Higashikubo R, Saunders BT, Bharat A, Goldstein DR, Krupnick AS, Gelman AE, Lavine KJ, Kreisel D. Heart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/ CXCL5 signaling. JCI Insight. 2016;1:1-14.
33. Dewald O, Zymek P, Winkelmann K, Koerting A, Ren G, Abou-Khamis T, Michael LH, Rollins BJ, Entman ML, Frangogiannis NG. CCL2/ monocyte chemoattractant protein-1 regulates infammatory responses critical to healing myocardial infarcts. Circ Res. 2005;96:881-889. doi: 10.1161/01.RES.0000163017.13772.3a.
34. Zouggari Y, Ait-Oufella H, Bonnin P, et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med. 2013;19:1273-1280. doi: 10.1038/nm.3284.
35. Jung K, Kim P, Leuschner F, Gorbatov R, Kim JK, Ueno T, Nahrendorf M, Yun SH. Endoscopic time-lapse imaging of immune cells in in-farcted mouse hearts. Circ Res. 2013;112:891-899. doi: 10.1161/ CIRCRESAHA.111.300484.
36. Hilgendorf I, Gerhardt LM, Tan TC, Winter C, Holderried TA, Chousterman BG, Iwamoto Y, Liao R, Zirlik A, Scherer-Crosbie M, Hedrick CC, Libby P, Nahrendorf M, Weissleder R, Swirski FK. Ly-6Chigh monocytes depend on Nr4a1 to balance both infammatory and reparative phases in the infarcted myocardium. Circ Res. 2014;114:1611-1622. doi: 10.1161/ CIRCRESAHA.114.303204.
37. Courties G, Heidt T, Sebas M, et al. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. J Am Coll Cardiol. 2014;63:1556-1566. doi: 10.1016/j. jacc.2013.11.023.
38. Leuschner F, Rauch PJ, Ueno T, et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med. 2012;209:123-137. doi: 10.1084/jem.20111009.
39. Dutta P, Courties G, Wei Y, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487:325-329. doi: 10.1038/nature11260.
40. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ. Identification of splenic reservoir monocytes and their deployment to infammatory sites. Science. 2009;325:612-616. doi: 10.1126/science.1175202.
41. Sager HB, Hulsmans M, Lavine KJ, et al. Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure. Circ Res. 2016;119:853-864. doi: 10.1161/CIRCRESAHA.116.309001.
42. Dunlay SM, Weston SA, Redfeld MM, Killian JM, Roger VL. Tumor necrosis factor-alpha and mortality in heart failure: a community study. Circulation. 2008;118:625-631. doi: 10.1161/ CIRCULATIONAHA.107.759191.
43. Papathanasiou S, Rickelt S, Soriano ME, Schips TG, Maier HJ, Davos CH, Varela A, Kaklamanis L, Mann DL, Capetanaki Y. Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18. Nat Med. 2015;21:1076-1084. doi: 10.1038/nm.3925.
44. Frangogiannis NG. The infammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11:255-265. doi: 10.1038/ nrcardio.2014.28.
45. van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJ. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol. 2007;170:818-829. doi: 10.2353/ajpath.2007.060547.
46. Leblond AL, Klinkert K, Martin K, Turner EC, Kumar AH, Browne T, Caplice NM. Systemic and cardiac depletion of M2 macrophage through CSF-1R signaling inhibition alters cardiac function post myo-cardial infarction. PLoS One. 2015;10:e0137515. doi: 10.1371/journal. pone.0137515.
47. Panizzi P, Swirski FK, Figueiredo JL, Waterman P, Sosnovik DE, Aikawa E, Libby P, Pittet M, Weissleder R, Nahrendorf M. Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol. 2010;55:1629-1638. doi: 10.1016/j.jacc.2009.08.089.
48. Cochain C, Auvynet C, Poupel L, et al. The chemokine decoy receptor D6 prevents excessive infammation and adverse ventricular remodeling after myocardial infarction. Arterioscler Thromb Vasc Biol. 2012;32:2206-2213. doi: 10.1161/ATVBAHA.112.254409.
49. Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing in infammatory monocytes in mice. Nat Biotechnol. 2011;29:1005-1010. doi: 10.1038/nbt.1989.
50. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:1810-1852. doi: 10.1161/CIR.0b013e31829e8807.
51. McMurray JJ, Adamopoulos S, Anker SD, et al; ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-1847. doi: 10.1093/eurheartj/ehs104.
52. Ismahil MA, Hamid T, Bansal SS, Patel B, Kingery JR, Prabhu SD. Remodeling of the mononuclear phagocyte network underlies chronic in-fammation and disease progression in heart failure: critical importance of the cardiosplenic axis. Circ Res. 2014;114:266-282. doi: 10.1161/ CIRCRESAHA.113.301720.
53. Leask A. Getting to the heart of the matter: new insights into cardiac fbrosis. Circ Res. 2015;116:1269-1276. doi: 10.1161/ CIRCRESAHA.116.305381.
54. Lafamme MA, Murry CE. Heart regeneration. Nature. 2011;473:326-335. doi: 10.1038/nature10147.
55. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafsh. Science. 2002;298:2188-2190. doi: 10.1126/science.1077857.
56. Kikuchi K, Holdway JE, Werdich AA, Anderson RM, Fang Y, Egnaczyk GF, Evans T, Macrae CA, Stainier DY, Poss KD. Primary contribution to zebrafsh heart regeneration by gata4(+) cardiomyocytes. Nature. 2010;464:601-605. doi: 10.1038/nature08804.
57. Jopling C, Sleep E, Raya M, Martí M, Raya A, Izpisúa Belmonte JC. Zebrafsh heart regeneration occurs by cardiomyocyte dedifferen-tiation and proliferation. Nature. 2010;464:606-609. doi: 10.1038/ nature08899.
58. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331:1078-1080. doi: 10.1126/science.1200708.
59. Haubner BJ, Adamowicz-Brice M, Khadayate S, Tiefenthaler V, Metzler B, Aitman T, Penninger JM. Complete cardiac regeneration in a mouse model of myocardial infarction. Aging (Albany NY). 2012;4:966-977. doi: 10.18632/aging.100526.
60. Jesty SA, Steffey MA, Lee FK, Breitbach M, Hesse M, Reining S, Lee JC, Doran RM, Nikitin AY, Fleischmann BK, Kotlikoff MI. c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc Natl Acad Sci U S A. 2012;109:13380-13385. doi: 10.1073/ pnas.1208114109.
61. Aurora AB, Porrello ER, Tan W, Mahmoud AI, Hill JA, Bassel-Duby R, Sadek HA, Olson EN. Macrophages are required for neonatal heart regeneration. J Clin Invest. 2014;124:1382-1392. doi: 10.1172/JCI72181.
62. Lavine KJ, Epelman S, Uchida K, Weber KJ, Nichols CG, Schilling JD, Ornitz DM, Randolph GJ, Mann DL. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc Natl Acad Sci U S A. 2014;111:16029-16034. doi: 10.1073/pnas.1406508111.
63. Mahmoud AI, O'Meara CC, Gemberling M, Zhao L, Bryant DM, Zheng R, Gannon JB, Cai L, Choi WY, Egnaczyk GF, Burns CE, Burns CG, MacRae CA, Poss KD, Lee RT Nerves regulate cardiomyocyte proliferation and heart regeneration. Dev Cell. 2015;34:387-399. doi: 10.1016/j. devcel.2015.06.017.
64. White IA, Gordon J, Balkan W, Hare JM. Sympathetic reinnervation is required for mammalian cardiac regeneration. Circ Res. 2015;117:990-994. doi: 10.1161/CIRCRESAHA.115.307465.
65. Uygur A, Lee RT. Mechanisms of cardiac regeneration. Dev Cell. 2016;36:362-374. doi: 10.1016/j.devcel.2016.01.018.
66. Shirai T, Hilhorst M, Harrison DG, Goronzy JJ, Weyand CM. Macrophages in vascular infammation-from atherosclerosis to vasculitis. Autoimmunity. 2015;48:139-151. doi: 10.3109/08916934.2015.1027815.
67. Bush E, Maeda N, Kuziel WA, Dawson TC, Wilcox JN, DeLeon H, Taylor WR. CC chemokine receptor 2 is required for macrophage infltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension. 2000;36:360-363.
68. Wenzel P, Knorr M, Kossmann S, et al. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation. 2011;124:1370-1381. doi: 10.1161/ CIRCULATIONAHA.111.034470.
69. Moore JP, Vinh A, Tuck KL, Sakkal S, Krishnan SM, Chan CT, Lieu M, Samuel CS, Diep H, Kemp-Harper BK, Tare M, Ricardo SD, Guzik TJ, Sobey CG, Drummond GR. M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fbrosis, elas-tin loss, and elevated blood pressure. Am J Physiol Heart Circ Physiol. 2015;309:H906-H917. doi: 10.1152/ajpheart.00821.2014.
70. Shah KH, Shi P, Giani JF, Janjulia T, Bernstein EA, Li Y, Zhao T, Harrison DG, Bernstein KE, Shen XZ. Myeloid suppressor cells accumulate and regulate blood pressure in hypertension. Circ Res. 2015;117:858-869. doi: 10.1161/CIRCRESAHA.115.306539.
71. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145:341-355. doi: 10.1016/j.cell.2011.04.005.
72. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204-212. doi: 10.1038/ni.2001.
73. Tall AR, Yvan-Charvet L. Cholesterol, infammation and innate immunity. Nat Rev Immunol. 2015;15:104-116. doi: 10.1038/nri3793.
74. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13:709-721. doi: 10.1038/ nri3520.
75. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.
76. Lafont A. Basic aspects of plaque vulnerability. Heart. 2003;89:1262-1267.
77. Franck G, Mawson T, Sausen G, et al. Flow perturbation mediates neutrophil recruitment and potentiates endothelial injury via TLR2 in mice: implications for superfcial erosion. Circ Res. 2017;121:31-42. doi: 10.1161/CIRCRESAHA.117.310694.
78. Robbins CS, Hilgendorf I, Weber GF, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med. 2013;19:1166-1172. doi: 10.1038/nm.3258.
79. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholes-terolemic mice. Circulation. 2008;117:1649-1657. doi: 10.1161/ CIRCULATIONAHA.107.745091.
80. Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins RM, Swiatlowska P, Newman AA, Greene ES, Straub AC, Isakson B, Randolph GJ, Owens GK. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med. 2015;21:628-637. doi: 10.1038/nm.3866.
81. Chappell J, Harman JL, Narasimhan VM, Yu H, Foote K, Simons BD, Bennett MR, Jørgensen HF. Extensive proliferation of a subset of differentiated, yet plastic, medial vascular smooth muscle cells contributes to neointimal formation in mouse injury and atherosclerosis models. Circ Res. 2016;119:1313-1323. doi: 10.1161/CIRCRESAHA.116.309799.
82. Sandison ME, Dempster J, McCarron JG. The transition of smooth muscle cells from a contractile to a migratory, phagocytic phenotype: direct demonstration of phenotypic modulation. J Physiol. 2016;594:6189-6209. doi: 10.1113/JP272729.
83. Shah PK, Yano J, Reyes O, Chyu KY, Kaul S, Bisgaier CL, Drake S, Cercek B. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-defcient mice. Potential implications for acute plaque stabilization. Circulation. 2001;103:3047-3050.
84. Tian F, Wang L, Arias A, Yang M, Sharif BG, Shah PK. Comparative antiatherogenic effects of intravenous AAV8-and AAV2-mediated ApoA-IMilano gene transfer in hypercholesterolemic mice. J Cardiovasc Pharmacol Ther. 2015;20:66-75. doi: 10.1177/1074248414530041.
85. Wang L, Tian F, Arias A, Yang M, Sharif BG, Shah PK. Comparative effects of diet-induced lipid lowering versus lipid lowering along with apo A-I Milano gene therapy on regression of atherosclerosis. J Cardiovasc Pharmacol Ther. 2016;21:320-328. doi: 10.1177/1074248415610216.
86. Lieu HD, Withycombe SK, Walker Q, Rong JX, Walzem RL, Wong JS, Hamilton RL, Fisher EA, Young SG. Eliminating atherogen-esis in mice by switching off hepatic lipoprotein secretion. Circulation. 2003;107:1315-1321.
87. Feig JE, Parathath S, Rong JX, Mick SL, Vengrenyuk Y, Grauer L, Young SG, Fisher EA. Reversal of hyperlipidemia with a genetic switch favorably affects the content and infammatory state of macrophages in atherosclerotic plaques. Circulation. 2011;123:989-998. doi: 10.1161/ CIRCULATIONAHA.110.984146.
88. Llodrá J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A. 2004;101:11779-11784. doi: 10.1073/pnas.0403259101.
89. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M, Fisher EA. HDL promotes rapid atherosclerosis regression in mice and alters infammatory properties of plaque mono-cyte-derived cells. Proc Natl Acad Sci U S A. 2011;108:7166-7171. doi: 10.1073/pnas.1016086108.
90. Rahman K, Vengrenyuk Y, Ramsey SA, Vila NR, Girgis NM, Liu J, Gusarova V, Gromada J, Weinstock A, Moore KJ, Loke P, Fisher EA. Infammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression. J Clin Invest. 2017;127:2904-2915. doi: 10.1172/JCI75005.
91. Ridker PM, MacFadyen JG, Thuren T, et al; CANTOS Trial Group. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390:1833-1842. doi: 10.1016/S0140-6736(17)32247-X.
92. Ridker PM, Everett BM, Thuren T,et al; CANTOS Trial Group. Antiinfammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119-1131. doi: 10.1056/NEJMoa1707914.
93. Ehninger A, Trumpp A. The bone marrow stem cell niche grows up: mes-enchymal stem cells and macrophages move in. J Exp Med. 2011;208:421-428. doi: 10.1084/jem.20110132.
94. Heideveld E, van den Akker E. Digesting the role of bone marrow mac-rophages on hematopoiesis. Immunobiology. 2017;222:814-822. doi: 10.1016/j.imbio.2016.11.007.
95. Winkler IG, Sims NA, Pettit AR, Barbier V, Nowlan B, Helwani F, Poulton IJ, van Rooijen N, Alexander KA, Raggatt LJ, Lévesque JP. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood. 2010;116:4815-4828. doi: 10.1182/blood-2009-11-253534.
96. Chow A, Lucas D, Hidalgo A, Méndez-Ferrer S, Hashimoto D, Scheiermann C, Battista M, Leboeuf M, Prophete C, van Rooijen N, Tanaka M, Merad M, Frenette PS. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med. 2011;208:261-271. doi: 10.1084/jem.20101688.
97. Dutta P, Hoyer FF, Grigoryeva LS, et al. Macrophages retain hematopoi-etic stem cells in the spleen via VCAM-1. J Exp Med. 2015;212:497-512. doi: 10.1084/jem.20141642.
98. McCabe A, Zhang Y, Thai V, Jones M, Jordan MB, MacNamara KC. Macrophage-lineage cells negatively regulate the hematopoietic stem cell pool in response to interferon gamma at steady state and during infection. Stem Cells. 2015;33:2294-2305. doi: 10.1002/stem.2040.
99. Basu S, Hodgson G, Katz M, Dunn AR. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Blood. 2002;100:854-861.
100. Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 2005;22:285-294. doi: 10.1016/j.immuni.2005.01.011.
101. Casanova-Acebes M, Pitaval C, Weiss LA, Nombela-Arrieta C, Chèvre R, A-González N, Kunisaki Y, Zhang D, van Rooijen N, Silberstein LE, Weber C, Nagasawa T, Frenette PS, Castrillo A, Hidalgo A. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell. 2013;153:1025-1035. doi: 10.1016/j.cell.2013.04.040.
102. Dutta P, Sager HB, Stengel KR, et al. Myocardial infarction activates CCR2(+) hematopoietic stem and progenitor cells. Cell Stem Cell. 2015;16:477-487. doi: 10.1016/j.stem.2015.04.008.
103. Sørensen MV, Pedersen S, Møgelvang R, Skov-Jensen J, Flyvbjerg A. Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2011;4:281-286. doi: 10.1016/j.jcin.2010.10.015.
104. Andrassy M, Volz HC, Riedle N, Gitsioudis G, Seidel C, Laohachewin D, Zankl AR, Kaya Z, Bierhaus A, Giannitsis E, Katus HA, Korosoglou G. HMGB1 as a predictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med. 2011;270:245-253. doi: 10.1111/j.1365-2796.2011.02369.x.
105. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5:331-342. doi: 10.1038/nri1594.
106. Morrow DA, Wang Y, Croce K, Sakuma M, Sabatine MS, Gao H, Pradhan AD, Healy AM, Buros J, McCabe CH, Libby P, Cannon CP, Braunwald E, Simon DI. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am Heart J. 2008;155:49-55. doi: 10.1016/j.ahj.2007.08.018.
107. Katashima T, Naruko T, Terasaki F, Fujita M, Otsuka K, Murakami S, Sato A, Hiroe M, Ikura Y, Ueda M, Ikemoto M, Kitaura Y. Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients. Circ J. 2010;74:741-748.
108. Schiopu A, Cotoi OS. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. Mediators Infamm. 2013;2013:828354. doi: 10.1155/2013/828354.
109. Guillén I, Blanes M, Gómez-Lechón MJ, Castell JV. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J Physiol. 1995;269:R229-R235.
110. Sager HB, Heidt T, Hulsmans M, Dutta P, Courties G, Sebas M, Wojtkiewicz GR, Tricot B, Iwamoto Y, Sun Y, Weissleder R, Libby P, Swirski FK, Nahrendorf M. Targeting interleukin-1β reduces leukocyte production after acute myocardial infarction. Circulation. 2015;132:1880-1890. doi: 10.1161/CIRCULATIONAHA.115.016160.
111. Geijtenbeek TB, Groot PC, Nolte MA, van Vliet SJ, Gangaram-Panday ST, van Duijnhoven GC, Kraal G, van Oosterhout AJ, van Kooyk Y. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood. 2002;100:2908-2916. doi: 10.1182/blood-2002-04-1044.
112. Karlsson MC, Guinamard R, Bolland S, Sankala M, Steinman RM, Ravetch JV. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med. 2003;198:333-340. doi: 10.1084/jem.20030684.
113. Nolte MA, Arens R, Kraus M, van Oers MH, Kraal G, van Lier RA, Mebius RE. B cells are crucial for both development and maintenance of the splenic marginal zone. J Immunol. 2004;172:3620-3627.
114. You Y, Myers RC, Freeberg L, Foote J, Kearney JF, Justement LB, Carter RH. Marginal zone B cells regulate antigen capture by marginal zone macrophages. J Immunol. 2011;186:2172-2181. doi: 10.4049/ jimmunol.1002106.
115. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5:606-616. doi: 10.1038/nri1669.
116. Dutta P, Hoyer FF, Sun Y, Iwamoto Y, Tricot B, Weissleder R, Magnani JL, Swirski FK, Nahrendorf M. E-selectin inhibition mitigates splenic HSC activation and myelopoiesis in hypercholesterolemic mice with myocardial infarction. Arterioscler Thromb Vasc Biol. 2016;36:1802-1808. doi: 10.1161/ATVBAHA.116.307519.
117. Kim E, Yang J, Beltran CD, Cho S. Role of spleen-derived monocytes/ macrophages in acute ischemic brain injury. J Cereb Blood Flow Metab. 2014;34:1411-1419. doi: 10.1038/jcbfm.2014.101.
118. Robbins CS, Chudnovskiy A, Rauch PJ, et al. Extramedullary he-matopoiesis generates Ly-6C(high) monocytes that infltrate atherosclerotic lesions. Circulation. 2012;125:364-374. doi: 10.1161/ CIRCULATIONAHA.111.061986.
119. Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med. 2013;19:1252-1263. doi: 10.1038/nm.3361.
120. Giralt M, Villarroya F. White, brown, beige/brite: different adipose cells for different functions? Endocrinology. 2013;154:2992-3000. doi: 10.1210/en.2013-1403.
121. Rosenwald M, Wolfrum C. The origin and defnition of brite versus white and classical brown adipocytes. Adipocyte. 2014;3:4-9. doi: 10.4161/ adip.26232.
122. Amano SU, Cohen JL, Vangala P, Tencerova M, Nicoloro SM, Yawe JC, Shen Y, Czech MP, Aouadi M. Local proliferation of macrophages contributes to obesity-associated adipose tissue infammation. Cell Metab. 2014;19:162-171. doi: 10.1016/j.cmet.2013.11.017.
123. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808. doi: 10.1172/ JCI19246.
124. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K, Kasuga M. MCP-1 contributes to macrophage infltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006;116:1494-1505. doi: 10.1172/ JCI26498.
125. Hassnain Waqas SF, Noble A, Hoang AC, Ampem G, Popp M, Strauß S, Guille M, Röszer T. Adipose tissue macrophages develop from bone marrow-independent progenitors in Xenopus laevis and mouse. J Leukoc Biol. 2017;102:845-855. doi: 10.1189/jlb.1A0317-082RR.
126. Brestoff JR, Artis D. Immune regulation of metabolic homeosta-sis in health and disease. Cell. 2015;161:146-160. doi: 10.1016/j. cell.2015.02.022.
127. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A. Macrophage-specifc PPARgamma controls alternative activation and improves insulin resistance. Nature. 2007;447:1116-1120. doi: 10.1038/nature05894.
128. Kang K, Reilly SM, Karabacak V, Gangl MR, Fitzgerald K, Hatano B, Lee CH. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 2008;7:485-495. doi: 10.1016/j.cmet.2008.04.002.
129. Szanto A, Balint BL, Nagy ZS, Barta E, Dezso B, Pap A, Szeles L, Poliska S, Oros M, Evans RM, Barak Y, Schwabe J, Nagy L. STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells. Immunity. 2010;33:699-712. doi: 10.1016/j.immuni.2010.11.009.
130. Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI, Jouihan H, Morel CR, Heredia JE, Mukundan L, Wu D, Locksley RM, Chawla A. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci U S A. 2010;107:22617-22622. doi: 10.1073/ pnas.1009152108.
131. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, Chawla A, Locksley RM. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science. 2011;332:243-247. doi: 10.1126/science.1201475.
132. Chang YH, Ho KT, Lu SH, Huang CN, Shiau MY. Regulation of glu-cose/lipid metabolism and insulin sensitivity by interleukin-4. Int J Obes (Lond). 2012;36:993-998. doi: 10.1038/ijo.2011.168.
133. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117:175-184. doi: 10.1172/JCI29881.
134. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity. 2014;41:36-48. doi: 10.1016/j.immuni.2014.05.010.
135. Shoelson SE, Lee J, Goldfne AB. Infammation and insulin resistance. J Clin Invest. 2006;116:1793-1801. doi: 10.1172/JCI29069.
136. Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118:547-563. doi: 10.1161/ CIRCRESAHA.115.306249.
137. Brown NK, Zhou Z, Zhang J, Zeng R, Wu J, Eitzman DT, Chen YE, Chang L. Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler Thromb Vasc Biol. 2014;34:1621-1630. doi: 10.1161/ATVBAHA.114.303029.
138. Öhman MK, Luo W, Wang H, Guo C, Abdallah W, Russo HM, Eitzman DT. Perivascular visceral adipose tissue induces atherosclerosis in apo-lipoprotein E defcient mice. Atherosclerosis. 2011;219:33-39. doi: 10.1016/j.atherosclerosis.2011.07.012.
139. Chang L, Villacorta L, Li R, Hamblin M, Xu W, Dou C, Zhang J, Wu J, Zeng R, Chen YE. Loss of perivascular adipose tissue on peroxisome pro-liferator-activated receptor-y deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation. 2012;126:1067-1078. doi: 10.1161/CIRCULATIONAHA.112.104489.
140. Poledne R, Králová Lesná I, Čejková S. Adipose tissue and atherosclerosis. Physiol Res. 2015;64 suppl 3:S395-S402.
141. Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, Meda P, Chizzolini C, Meier CA. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol. 2005;25:2594-2599. doi: 10.1161/01. ATV.0000188508.40052.35.
142. Rittig K, Dolderer JH, Balletshofer B, Machann J, Schick F, Meile T, Küper M, Stock UA, Staiger H, Machicao F, Schaller HE, Königsrainer A, Häring HU, Siegel-Axel DI. The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells. Diabetologia. 2012;55:1514-1525. doi: 10.1007/s00125-012-2481-9.
143. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, O'Donnell CJ, Fox CS. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117:605-613. doi: 10.1161/CIRCULATIONAHA.107.743062.
144. Liu J, Fox CS, Hickson D, Sarpong D, Ekunwe L, May WD, Hundley GW, Carr JJ, Taylor HA. Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson heart study. Diabetes Care. 2010;33:1635-1639. doi: 10.2337/dc10-0245.
145. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci. 2007;10:1538-1543. doi: 10.1038/nn2014.
146. Erblich B, Zhu L, Etgen AM, Dobrenis K, Pollard JW. Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory defcits. PLoS One. 2011;6:e26317. doi: 10.1371/journal.pone.0026317.
147. Varvel NH, Grathwohl SA, Baumann F, Liebig C, Bosch A, Brawek B, Thal DR, Charo IF, Heppner FL, Aguzzi A, Garaschuk O, Ransohoff RM, Jucker M. Microglial repopulation model reveals a robust homeo-static process for replacing CNS myeloid cells. Proc Natl Acad Sci U S A. 2012;109:18150-18155. doi: 10.1073/pnas.1210150109.
148. Prokop S, Miller KR, Drost N, Handrick S, Mathur V, Luo J, Wegner A, Wyss-Coray T, Heppner FL. Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer's disease-like mice. J Exp Med. 2015;212:1811-1818. doi: 10.1084/jem.20150479.
149. Bruttger J, Karram K, Wörtge S, et al. Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system. Immunity. 2015;43:92-106. doi: 10.1016/j.immuni.2015.06.012.
150. Elmore MR, Najaf AR, Koike MA, Dagher NN, Spangenberg EE, Rice RA, Kitazawa M, Matusow B, Nguyen H, West BL, Green KN. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron. 2014;82:380-397. doi: 10.1016/j.neuron.2014.02.040.
151. Ueno M, Fujita Y, Tanaka T, Nakamura Y, Kikuta J, Ishii M, Yamashita T Layer V cortical neurons require microglial support for survival during postnatal development. Nat Neurosci. 2013;16:543-551. doi: 10.1038/nn.3358.
152. Marín-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. Microglia promote the death of developing Purkinje cells. Neuron. 2004;41:535-547.
153. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without infammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 2005;201:647-657. doi: 10.1084/ jem.20041611.
154. Roumier A, Béchade C, Poncer J-C, Smalla K-H, Tomasello E, Vivier E, Gundelfnger ED, Triller A, Bessis A. Impaired synaptic function in the microglial KARAP/DAP12-defcient mouse. J Neurosci. 2004;24:11421-11428.
155. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, Gross CT. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456-1458. doi: 10.1126/science.1202529.
156. Zeisel A, Muñoz-Manchado AB, Codeluppi S, Lönnerberg P, La Manno G, Juréus A, Marques S, Munguba H, He L, Betsholtz C, Rolny C, Castelo-Branco G, Hjerling-Leffer J, Linnarsson S. Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science. 2015;347:1138-1142. doi: 10.1126/science.aaa1934.
157. Prinz M, Erny D, Hagemeyer N. Ontogeny and homeostasis of CNS my-eloid cells. Nat Immunol. 2017;18:385-392. doi: 10.1038/ni.3703.
158. Goldmann T, Wieghofer P, Jordão MJ, et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat Immunol. 2016;17:797-805. doi: 10.1038/ni.3423.
159. Streit WJ, Graeber MB, Kreutzberg GW. Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury. Exp Neurol. 1989;105:115-126.
160. Kida S, Steart P V, Zhang ET, Weller RO. Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from peri-cytes, microglia and macrophages. Acta Neuropathol. 1993;85:646-652.
161. Elmquist JK, Breder CD, Sherin JE, Scammell TE, Hickey WF, Dewitt D, Saper CB. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and menin-geal macrophages. J Comp Neurol. 1997;381:119-129.
162. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA, Arumugam TV, Orthey E, Gerloff C, Tolosa E, Magnus T. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke. 2009;40:1849-1857. doi: 10.1161/STROKEAHA.108.534503.
163. Hammond MD, Taylor RA, Mullen MT, Ai Y, Aguila HL, Mack M, Kasner SE, McCullough LD, Sansing LH. CCR2+ Ly6C(hi) infamma-tory monocyte recruitment exacerbates acute disability following intra-cerebral hemorrhage. J Neurosci. 2014;34:3901-3909. doi: 10.1523/ JNEUROSCI.4070-13.2014.
164. Ma Y, Li Y, Jiang L, Wang L, Jiang Z, Wang Y, Zhang Z, Yang GY. Macrophage depletion reduced brain injury following middle cerebral artery occlusion in mice. J Neuroinfammation. 2016;13:38. doi: 10.1186/ s12974-016-0504-z.
165. Gliem M, Mausberg AK, Lee JI, Simiantonakis I, van Rooijen N, Hartung HP, Jander S. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol. 2012;71:743-752. doi: 10.1002/ ana.23529.
166. Schmidt A, Strecker JK, Hucke S, Bruckmann NM, Herold M, Mack M, Diederich K, Schäbitz WR, Wiendl H, Klotz L, Minnerup J. Targeting different monocyte/macrophage subsets has no impact on outcome in experimental stroke. Stroke. 2017;48:1061-1069. doi: 10.1161/ STROKEAHA.116.015577.
167. Szalay G, Martinecz B, Lénárt N, Környei Z, Orsolits B, Judák L, Császár E, Fekete R, West BL, Katona G, Rózsa B, Dénes Á. Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke. Nat Commun. 2016;7:11499. doi: 10.1038/ncomms11499.
168. Jin WN, Shi SX, Li Z, Li M, Wood K, Gonzales RJ, Liu Q. Depletion of microglia exacerbates postischemic infammation and brain injury. J Cereb Blood Flow Metab. 2017;37:2224-2236. doi: 10.1177/0271678X17694185.
169. Faraco G, Sugiyama Y, Lane D, Garcia-Bonilla L, Chang H, Santisteban MM, Racchumi G, Murphy M, Van Rooijen N, Anrather J, Iadecola C. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J Clin Invest. 2016;126:4674-4689. doi: 10.1172/JCI86950.
170. Hoeffel G, Wang Y, Greter M, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med. 2012;209:1167-1181. doi: 10.1084/jem.20120340.
171. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, Geissmann F. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012;336:86-90. doi: 10.1126/ science.1219179.
172. Stadtfeld M, Ye M, Graf T. Identification of interventricular septum precursor cells in the mouse embryo. Dev Biol. 2007;302:195-207. doi: 10.1016/j.ydbio.2006.09.025.
173. van Rooijen N, van Kesteren-Hendrikx E. Clodronate liposomes: perspectives in research and therapeutics. J Liposome Res. 2002;12:81-94. doi: 10.1081/LPR-120004780.
174. Majmudar MD, Keliher EJ, Heidt T, et al. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation. 2013;127:2038-2046. doi: 10.1161/ CIRCULATIONAHA.112.000116.
175. Sager HB, Dutta P, Dahlman JE, et al. RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular infamma-tion after myocardial infarction. Sci Transl Med. 2016;8:342ra80. doi: 10.1126/scitranslmed.aaf1435.
176. Tang J, Lobatto ME, Hassing L, et al. Inhibiting macrophage proliferation suppresses atherosclerotic plaque infammation. Sci Adv. 2015;1. pii: e1400223.
177. Duivenvoorden R, Tang J, Cormode DP, et al. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque infammation. Nat Commun. 2014;5:3065. doi: 10.1038/ncomms4065.
178. Lobatto ME, Fayad ZA, Silvera S, et al. Multimodal clinical imaging to longitudinally assess a nanomedical anti-infammatory treatment in experimental atherosclerosis. Mol Pharm. 2010;7:2020-2029. doi: 10.1021/mp100309y.
179. van der Valk FM, van Wijk DF, Lobatto ME, et al. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. Nanomedicine. 2015;11:1039-1046. doi: 10.1016/j.nano.2015.02.021.
180. Keliher EJ, Ye YX, Wojtkiewicz GR, et al. Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease. Nat Commun. 2017;8:14064. doi: 10.1038/ ncomms14064.
181. McArdle S, Chodaczek G, Ray N, Ley K. Intravital live cell triggered imaging system reveals monocyte patrolling and macrophage migration in atherosclerotic arteries. J Biomed Opt. 2015;20:26005. doi: 10.1117/1. JBO.20.2.026005.
182. Lo Celso C, Fleming HE, Wu JW, Zhao CX, Miake-Lye S, Fujisaki J, Côté D, Rowe DW, Lin CP, Scadden DT. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature. 2009;457:92-96. doi: 10.1038/nature07434.
183. Courties G, Herisson F, Sager HB, Heidt T, Ye Y, Wei Y, Sun Y, Severe N, Dutta P, Scharff J, Scadden DT, Weissleder R, Swirski FK, Moskowitz MA, Nahrendorf M. Ischemic stroke activates hematopoietic bone marrow stem cells. Circ Res. 2015;116:407-417. doi: 10.1161/ CIRCRESAHA.116.305207.
184. Tarkin JM, Joshi FR, Rudd JH. PET imaging of infammation in atherosclerosis. Nat Rev Cardiol. 2014;11:443-457. doi: 10.1038/ nrcardio.2014.80.
185. Folco EJ, Sheikine Y, Rocha VZ, Christen T, Shvartz E, Sukhova GK, Di Carli MF, Libby P. Hypoxia but not infammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fuorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol. 2011;58:603-614. doi: 10.1016/j. jacc.2011.03.044.
186. Pedersen SF, Græbe M, Hag AM, Højgaard L, Sillesen H, Kjær A. (18) F-FDG imaging of human atherosclerotic carotid plaques refects gene expression of the key hypoxia marker HIF-1α. Am J Nucl Med Mol Imaging. 2013;3:384-392.
187. Nahrendorf M, Zhang H, Hembrador S, Panizzi P, Sosnovik DE, Aikawa E, Libby P, Swirski FK, Weissleder R. Nanoparticle PET-CT imaging of macrophages in infammatory atherosclerosis. Circulation. 2008;117:379-387. doi: 10.1161/CIRCULATIONAHA.107.741181.
188. Majmudar MD, Yoo J, Keliher EJ, Truelove JJ, Iwamoto Y, Sena B, Dutta P, Borodovsky A, Fitzgerald K, Di Carli MF, Libby P, Anderson DG, Swirski FK, Weissleder R, Nahrendorf M. Polymeric nanoparticle PET/ MR imaging allows macrophage detection in atherosclerotic plaques. Circ Res. 2013;112:755-761. doi: 10.1161/CIRCRESAHA.111.300576.
189. Junker A, Kokornaczyk AK, Zweemer AJ, et al. Synthesis, binding af-fnity and structure-activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonists. Org Biomol Chem. 2015;13:2407-2422. doi: 10.1039/c4ob02397h.
190. Luehmann HP, Detering L, Fors BP, Pressly ED, Woodard PK, Randolph GJ, Gropler RJ, Hawker CJ, Liu Y. PET/CT imaging of chemokine receptors in infammatory atherosclerosis using targeted nanoparticles. J Nucl Med. 2016;57:1124-1129.
191. Wan MYS, Endozo R, Michopoulou S, Shortman R, Rodriguez-Justo M, Menezes L, Yusuf S, Richards T, Wild D, Waser B, Reubi JC, Groves A. PET/CT imaging of unstable carotid plaque with (68)Ga-labeled so-matostatin receptor ligand. J Nucl Med. 2017;58:774-780. doi: 10.2967/ jnumed.116.181438.
192. Tarkin JM, Joshi FR, Evans NR, et al. Detection of atherosclerotic in-fammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging. J Am Coll Cardiol. 2017;69:1774-1791. doi: 10.1016/j. jacc.2017.01.060.
193. Cerami C, Perani D. Imaging neuroinfammation in ischemic stroke and in the atherosclerotic vascular disease. Curr Vasc Pharmacol. 2015;13:218-222.
194. Dollé F, Luus C, Reynolds A, Kassiou M. Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. Curr Med Chem. 2009;16:2899-2923.
195. Zinnhardt B, Viel T, Wachsmuth L, et al. Multimodal imaging reveals temporal and spatial microglia and matrix metalloproteinase activity after experimental stroke. J Cereb Blood Flow Metab. 2015;35:1711-1721. doi: 10.1038/jcbfm.2015.149.
196. Cosenza-Nashat M, Zhao ML, Suh HS, Morgan J, Natividad R, Morgello S, Lee SC. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol. 2009;35:306-328. doi: 10.1111/j.1365-2990.2008.01006.x.
197. Mandal PK, Ferreira LM, Collins R, et al. Effcient ablation of genes in human hematopoietic stem and effector cells using CRISPR/Cas9. Cell Stem Cell. 2014;15:643-652. doi: 10.1016/j.stem.2014.10.004.
198. Heckl D, Kowalczyk MS, Yudovich D, Belizaire R, Puram RV, McConkey ME, Thielke A, Aster JC, Regev A, Ebert BL. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Nat Biotechnol. 2014;32:941-946. doi: 10.1038/nbt.2951.
199. Gundry MC, Brunetti L, Lin A, Mayle AE, Kitano A, Wagner D, Hsu JI, Hoegenauer KA, Rooney CM, Goodell MA, Nakada D. Highly ef-fcient genome editing of murine and human hematopoietic progenitor cells by CRISPR/Cas9. Cell Rep. 2016;17:1453-1461. doi: 10.1016/j. celrep.2016.09.092.
200. Dever DP, Bak RO, Reinisch A, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389. doi: 10.1038/nature20134.